Subclinical systemic inflammation is a hallmark of obesity and insulin resistance. The results obtained from a number of experimental studies suggest that targeting different components of the inflammatory machinery may result in the improvement of the metabolic phenotype. Unsaturated fatty acids exert antiinflammatory activity through several distinct mechanisms. Here, we tested the capacity of 3 and 9 fatty acids, directly from their food matrix, to exert antiinflammatory activity through the G protein-coupled receptor (GPR)120 and GPR40 pathways. GPR120 was activated in liver, skeletal muscle, and adipose tissues, reverting inflammation and insulin resistance in obese mice. Part of this action was also mediated by GPR40 on muscle, as a novel mechanism described. Pair-feeding and immunoneutralization experiments reinforced the pivotal role of GPR120 as a mediator in the response to the nutrients. The improvement in insulin sensitivity in the high-fat substituted diets was associated with a marked reduction in tissue inflammation, decreased macrophage infiltration, and increased IL-10 levels. Furthermore, improved glucose homeostasis was accompanied by the reduced expression of hepatic gluconeogenic enzymes and reduced body mass. Thus, our data indicate that GPR120 and GPR40 play a critical role as mediators of the beneficial effects of dietary unsaturated fatty acids in the context of obesity-induced insulin resistance. (Endocrinology 156: 4033-4046, 2015) 
Subclinical systemic inflammation is a hallmark of obesity and insulin resistance. The results obtained from a number of experimental studies suggest that targeting different components of the inflammatory machinery may result in the improvement of the metabolic phenotype. Unsaturated fatty acids exert antiinflammatory activity through several distinct mechanisms. Here, we tested the capacity of 3 and 9 fatty acids, directly from their food matrix, to exert antiinflammatory activity through the G protein-coupled receptor (GPR)120 and GPR40 pathways. GPR120 was activated in liver, skeletal muscle, and adipose tissues, reverting inflammation and insulin resistance in obese mice. Part of this action was also mediated by GPR40 on muscle, as a novel mechanism described. Pair-feeding and immunoneutralization experiments reinforced the pivotal role of GPR120 as a mediator in the response to the nutrients. The improvement in insulin sensitivity in the high-fat substituted diets was associated with a marked reduction in tissue inflammation, decreased macrophage infiltration, and increased IL-10 levels. Furthermore, improved glucose homeostasis was accompanied by the reduced expression of hepatic gluconeogenic enzymes and reduced body mass. Thus, our data indicate that GPR120 and GPR40 play a critical role as mediators of the beneficial effects of dietary unsaturated fatty acids in the context of obesity-induced insulin resistance. (Endocrinology 156: 4033-4046, 2015) T he increasing global incidence of obesity and type 2 diabetes mellitus is regarded as one of the most challenging contemporary threats to public health (1) . It is now clear that obesity and obesity-related disorders, including insulin resistance and type 2 diabetes, are associated with a metabolically driven, low-grade, chronic inflammatory state referred to as metaflammation. Several inflammatory cytokines, as well as lipids and metabolic stress pathways, can activate metaflammation (2) . Impaired insulin-mediated inhibition of hepatic glucose production in the liver, decreased insulin-stimulated glucose uptake into skeletal muscle, and reduced ability of insulin to inhibit lipolysis in adipose tissue are some of the main outcomes of insulin resistance (2) . In these tissues, unsaturated fatty acids have well-known antiinflammatory effects, ranging from inhibiting the lipoxygenase and cyclooxygenase pathways (3) and decreasing neutrophil adhesion (3, 4) to reducing inflammatory cytokine levels (5) and inhibiting Toll Like Receptor 4 signaling (4). However, these mechanisms are poorly understood. Recently, a number of studies have reported that 5 orphan receptors, G protein-coupled receptor (GPR)40, GPR41, GPR43, GPR84, and GPR120, can be activated by free fatty acids (FFAs) and, in certain contexts, can deliver an antiinflammatory signal (6) .
In cell culture or in a restricted number of in vivo studies, GPR120 can be activated by isomers of 3 (C18:3, C20:5, and C22:6) and 9 (C18:1) fatty acids, apparently mediating some classical antiinflammatory activities attributed to these long-chain fats (7, 8) . Nevertheless, despite the enthusiasm regarding the therapeutic avenue opened by these reports, the mechanisms behind the beneficial effects of 3 and 9 fatty acids are still not completely elucidated. In the present study, the objective was to investigate the role of ␣-linolenic (C18:3) and oleic (C18:1) acids provided by food sources, such as flaxseed oil (FS) and olive oil (OL), respectively, for their capacity to disrupt the inflammatory cascade and reverse insulin resistance in tissues with important metabolic function. As a whole, we demonstrate that either 3-or 9-rich diets improve whole-body insulin resistance in an animal model of diet-induced obesity. Either diet produced an improvement of insulin signal transduction in metabolically relevant tissues (liver, skeletal muscle, and white adipose), which was accompanied by reduced inflammation. Finally, we show that both 3 and 9 fatty acids can activate signal transduction through GPR120.
Materials and Methods

Experimental animals
Male, 4-week-old Swiss mice (Mus musculus) were obtained from the State University of Campinas Breeding Center. Animals with an initial body mass of 15 g were included in the study and were allowed access to either standard rodent chow (control diet [CT]) or a high-fat diet (HF) for 8 weeks. Thereafter, mice on CT remained on that diet, whereas mice on HF were subdivided into 3 groups: maintained on HF, HF ϩ FS (10% of total caloric value), or HF ϩ OL (10% of total caloric value) for another 8 weeks, as described below and in Table  1 . The general protocol is presented in Figure 1A . All animals received food and water ad libitum and were maintained in individual cages at 21 Ϯ 2°C with a 12-hour light, 12-hour dark cycle. The diets were prepared in accordance with the guidelines of the American Institute of Nutrition (AIN-93G) (9) . Food intake was measured daily, and body mass was evaluated weekly. All experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Experimental Animals and were approved by the University of Campinas Ethical Committee (ID-2842-1). The detailed compositions of the diets were obtained by gas chromatography analysis, which is presented in Tables 1 and   2 . The HF contained 36.6% saturated fat, whereas the chow contained 17.2%. The 10% FS substitution led to an increase in the 3 component of the diet from 1.3% to 16.4%, whereas the 10% OL substitution led to an increase in the 9 component of the diet from 43.1% to 45.4%. No lipopolysaccarides contamination was detected in the diets, as determined by HPLC. Additionally, some mice were evaluated in a pair-feeding protocol ( Figure 1B ). For that experiment, mice fed on HF for 8 weeks were distributed into 3 groups (HF, FS, or OL). Based on previous measurements, food intake of the OL group was adopted as the standard for pair-feeding in the HF and FS groups. Finally, in a separate set of experiments, diet preference was tested in obese male Swiss mice that were fasted for 12 hours and then exposed simultaneously to 3 containers with equal amounts of 3 different diets. The amount of each diet consumed over a period of 12 hours was recorded, and the caloric value was calculated. The results are presented as the relative preference for each of the diets, as obtained from the ratio of caloric intake from each diet.
GPR120 neutralizing antibody
Initially, mice fed on HF for 8 weeks were randomly selected for treatment with saline, rabbit preimmune serum or rabbit antiserum against GPR120 (GPR120 Ab). To evaluate the capacity of the antiserum to neutralize GPR120 in the liver, skeletal muscle, or adipose tissue, doses of 1.25-and 0.625-g antibody diluted in 100-L saline were tested in a protocol consisting of 1 dose delivered by ip injection every other day for 30 days. Neutralizing efficiency was evaluated at the end of the experimental period by immunoprecipitating total protein samples obtained from the liver, skeletal muscle, and adipose tissue with anti-␤-arrestin followed by immunoblotting with a GPR120 antibody. The 1.25-g dose was selected for use in the remaining experiments. Additionally, lean mice were treated acutely with a GPR120 Ab to test the affinity and capacity of injected lipids to activate the GPR120 signaling cascade. After 8 hours of fasting, mice were treated with a GPR120 Ab or rabbit preimmune serum and, 3 hours later, with 500 L of solubilized lard, soy, flaxseed oil, or olive oil by oral gavage. 
GPR120 knockdown by lentivirus
As previously described, mice fed with HF were randomly selected for treatment with 3 different sequences of Sigma-Aldrich lentiviral particles to inhibit GPR120 transcription . The  sequence 1 CCG GGC TCA TGG TTT CCT TCT TCA TCT CGA  ATG AGA GGA ACC TGA CTT TT, TRCN0000026259, sequence  2 CCG GCG AAA TGA CTT GTC TGT TAT TCT CGA GAA TAA  CAG ACA AGT CAT TTC GTT TTT, TRCN0000026291,  orsequence3CCGGGCCAGCAAATTAAGGAATGATCTCGA  GAT CAT TCC TTA ATT TGC TGG CTT TTT, TRCN-0000026321 (10 7 lentiviral particles in 100 L) was administered via caudal vein as a single dose. As control, we used a scrambled sequence (Nontarget short RNA control, SHC016V). After 7 days, mice were food deprived for 8 hours, and subsequently, they were treated with 500 L of FS by oral gavage. After 3 hours, the animals were employed in experiments for determination of coimmunoprecipitation of ␤-arrestin and GPR120 in liver, muscle, and adipose tissue.
Antibodies, chemicals, and buffers
The reagents for SDS-PAGE and immunoblotting were from Bio-Rad. Human recombinant insulin (Humulin R) was from ] FoxO1 (9461S, rp), anti-TAB1) (3225, rp), antiglycogen synthase kinase-␣␤ (GSK-3␣/␤) (5676, rm), antiphospho-GSK-3␤ (5558, rm), and anti-␤-arrestin 2 (3857, rm) were from Cell Signaling). Anti-IL-1␤ (503502, mouse-rat) and anti-TNF␣ (506102, mouse-rat) were from BioLegend.
Gas chromatography method for the evaluation of diet composition
The fatty acids present in the diets were separated by a Dulbecco-23 capillary column in gas chromatograph (CGC-6850 Series Gas Chromatography System; Agilent Technologies). Extracted lipids were stored at Ϫ20°C, protected from light (10) .
Intraperitoneal insulin tolerance test (ITT)
After 8 hours of fasting, mice groups were submitted to an ITT (1 U/kg body weight Ϫ1 of insulin). Mice were injected with insulin, and blood samples were collected from 0 to 30 minutes from the tail vein for serum glucose determination. The constant for the rate of serum glucose disappearance was calculated using the formula 0.693/biological half-life (t 1/2 ). The plasma glucose t 1/2 was calculated from the slope of last square analysis of the plasma glucose concentration during the linear phase of decline (n ϭ 9) (11).
Intraperitoneal glucose tolerance test (GTT)
After 8 hours of fasting, mice were submitted to a GTT. After collection of an unchallenged sample (time 0), a solution of 20% glucose (2.0 g/kg body weight) was administered ip. Blood samples were collected from the tail vein from 0 to 120 minutes for determination of glucose concentrations. Results are presented as the area under glucose curves. Blood glucose of both ip ITT or ip GTT were determined using Accutrend Plus equipment (Roche).
HPLC for determination of LPS contamination
Determination of LPS content in diets was performed using a HPLC method described previously (12) . Briefly, fatty acids of the diet were derivatized with 4-bromomethyl-7-coumarin and the analysis performed in a Shimadzu model LC-10A liquid chromatographer. For quantification of fatty acids, the capacity factor, elution sequence, linearity, recovery, precision, interference, and limit of detection were determined. The lower limit of detection was 1.0 pg, and highly purified LPS was used as a tracer.
Mass spectrometry for the evaluation of liver lipid content
Sample preparation and analysis
Liver samples were submitted to sorptive tape-like extraction laser desorption ionization coupled with mass spectrometry imaging with direct stamping onto a silica gel (60 Å) plate for thin-layer chromatography (Merck), as described previously (13) . The metabolic fingerprint of FFAs was performed using a matrix-assisted laser desorption ionization model LTQ-XL instrument with tissue imaging feature (Thermo Fisher). Data acquisition for survey scan was performed at the m/z range of 150 -600 in the negative ion mode. Not any matrix was applied.
Histological studies
Epididymal fat or liver fragment specimen was dehydrated with ethanol, cleared with xylene, and embedded in paraffin wax (Histosec-Merck), and 4-mm sections were obtained (Olympus microtome). The epididymal tissue sections were stained with hematoxylin and eosin. The mean area of adipocytes (average surface area of 30 randomly sorted adipocytes, per animal) was determined by the ImageJ (National Institutes of Health). Liver slices were evaluated by indirect immunofluorescence staining with CD11b ϩ and GPR120, as described previously (8) . Analysis and documentation of results were performed using a Leica FW 4500 B microscope. ). The supernatants of these tissues were used for protein quantification, using the Bradford method (14) . Samples containing 125 mg of protein extracts were separated by SDS-PAGE, transferred to nitrocellulose membranes, and blotted with specific antibodies. Specific bands were labeled by chemiluminescence, and visualization was performed by exposure of the membranes to x-ray-films. For the evaluation of GPR120 and GPR40 signal transduction, 500-mg protein was used for immunoprecipitation.
Immunoblots and immunoprecipitation
Real-time PCR
Reverse transcription was performed using total RNA from liver samples, as described previously (15) . Intron-skipping primers for IL-6 and IL-10 and glyceraldehyde-3-phosphate dehydrogenase primers were obtained from Applied Biosystems. Real-time PCR analysis of gene expression was performed in an ABI Prism 7700 sequence detection system (Applied Biosystems).
Inflammatory score
The inflammatory score was calculated as follows: each tissue cytokine value was stratified into quintiles to determine cutoff points and assign a score ranging from 1, which was assigned to the lowest quintile, to 5, which was assigned to the highest quintiles; IL-1␤, IL-6, P-IKK, P-IB␣, TNF␣, and P-JNK are proinflammatory cytokines, whereas IL-10 is an antiinflammatory cytokine; therefore, the inflammatory score was calculated for each group as the sum of each cytokine score derived from the proinflammatory cytokines, from which the score derived from the IL-10 was subtracted divided by the sum of each cytokine score independently of being pro-or antiinflammatory. This protocol was adapted from Daniele et al (16) .
Statistical analysis
Specific protein bands present in the blots were quantified by digital densitometry program (UN-SCAN-IT, Silk Scientific). All data were subjected to the KolmogorovSmirnovtesttocheckforsymmetry.Forvariables with normal distribution, Student's t testwasusedtocompare2independentsam-ples (CT and HF groups). Analysis of variance was used to compare independent samples. Mean values Ϯ SD were compared using Tukey's test, and P Ͻ .05 was accepted as statistically significant. The number of mice used in distinct experiments is shown in the figure legends.
Results
FS and OL substitutions reduce body mass gain and adiposity
Either FS or OL substitution led to reduced body mass gain ( Figure 1C ) over a period of 60 days, resulting in a significantly lower body mass at the end of the experimental period compared with HF ( Figure  1D ). The body mass reductions in the FS and OL groups were accompanied by reduced epididymal fat pad content ( Figure  1E ) and reduced mean adipocyte diameter (Figure 1 , F and G). To evaluate the possible impact of taste on food consumption ( Figure 1I ), a food preference assay was carried out as previously described (17) . As depicted in Figure 1H , mice presented no significant difference in the preference for either diet. In addition, we evaluated the impact of FS and OL on caloric intake when mice returned to HF. For that, mice were initially fed on HF for 8 weeks, then transferred to either FS or OL for 4 weeks, and finally placed back on HF. As depicted in Figure 1J , the exposure of obese mice to FS or OL did not change its feeding behavior when reexposed to HF.
FS and OL substitutions improve glucose homeostasis and insulin action
HF produced a significant increase in the fasting blood glucose levels, which were normalized in the FS or OL groups ( Figure 2A ). As depicted in Figure 2 , B and B1 and C and C1, both the FS and OL substitutions produced significant reductions in ITT and the glucose area under the curve during a GTT. Immunoblot analysis revealed that insulin-stimulated tyrosine phosphorylation of IR and IRS-1 and serine phosphorylation of Akt in the liver (Figure 3 
FS and OL substitutions reduce diet-induced inflammation
Mice fed HF presented increased expression of a number of inflammatory markers in the liver (Figure 4, A-F) , muscle, and adipose tissue. (Supplemental Figure 5 , A-P) Both FS and OL substitutions produced significant reduc- press.endocrine.org/journal/endo 4039 tions in the expression or phosphorylation on proinflammatory markers, such as IL-1␤, IL-6, P-IKK, P-IB␣, TNF␣, and P-JNK, in the liver (Figure 4 , A-F), skeletal muscle, and adipose tissue. The expression levels of the antiinflammatory marker IL-10 were regulated in a diet-and tissue-specific pattern. Therefore, although OL produced significant increases in IL-10 expression in all tissues evaluated ( Figure  4G ), FS produced a significant increase in IL-10 expression only in the liver ( Figure 4G ). We performed an inflammatory score to predicted a global view by each tissue ( Figure 4H ). OL group shown a better antiinflammatory profile, apparently mediated by IL-10, in all tissues.
FS and OL change liver lipid composition
The macroscopic appearance of the liver was completely modified by either FS or OL. Mice fed HF presented with a yellowish and hypertrophic liver, which was reverted by FS or OL (Supplemental Figure 1) . Markers of gluconeogenesis were also reduced by both FS and OL. The inhibitory phosphorylation of GSK-3 and FoxO1 was increased, whereas the expression levels of PEPCK and G6Pase were decreased (Supplemental Figure 2) . In addition, both FS and OL caused a reduction in the presence of CD11b ϩ cells colocalized with GPR120 in the liver (Supplemental Figure 3) . FS (Supplemental Figure 4B ) and OL (Supplemental Figure  4C ) resulted in a modification of the liver fatty acid composition as compared with HF (Supplemental Figure 4A) , with a particular increase of C18:3 (Supplemental Figure 4D) and C18:1 (Supplemental Figure 4E ) content in the livers of FSand OL-fed mice, respectively. This is similar to changes promoted in the composition of blood FFAs as recently published by our group (8) .
The beneficial effects of FS and OL are not dependent on caloric intake A pair-feeding experiment was undertaken to evaluate a possible role for different caloric intake on the beneficial effects of the FS and OL diets. As depicted in Supplemental Figure 6 , pair-feeding (Supplemental Figure 6A ) resulted in very similar body mass (Supplemental Figure 6 , B and C) and adiposity (Supplemental Figure 6D) at the end of the experimental period. However, there was retention of the beneficial effects of both diets on insulin signal transduction in the liver ( Figure 5 , A-C), muscle (Supplemental Figure 7 , A-C), and adipose tissue (Supplemental Figure 7 , H-J), as well as on the expression of inflammatory markers in the liver (Figure 5 , D-G), muscle (Supplemental Figure 7, D-G) , and adipose tissue (Supplemental Figure 7 , K-N).
GPR120 is activated by fatty acids present in the diet
To evaluate the capacity of fatty acids present in the diet to activate GPR120 signaling in insulin-sensitive tissues, mice fasted for 8 hours were treated with 500 L of soy, FS, or OL or with lard, by oral gavage. As depicted in Figure 6 , all fatty acid sources were capable of inducing the recruitment of ␤-arrestin to GPR120. As press.endocrine.org/journal/endoexpected, flaxseed, which is both a source for 3 and a known high-affinity ligand for the GPR120 (7, 8) , produced the most potent induction of the GPR120/␤-arrestin association in all tissues ( Figure 6 , A-C). As a rule, the greatest activation of GPR120 occurred at 150 and 180 minutes ( Figure 6 , D, E, and G). In muscle, GPR40 signaling was also stimulated ( Figure 6F ). Next, mice fed FS or OL were evaluated for the activation of the complete GPR120 signaling cascade. To test GPR120 intracelular signaling, both FS and OL treatment resulted in the increased association of GPR120 with ␤-arrestin (Supplemental Figure 8 , A, D, and G) accompanied by the increased recruitment of TAB1/2 (Supplemental Figure 8 , B, E, and H) to the GPR120/ ␤-arrestin complex and the displacement of TAK from its association with TAB1/2 in the liver (Supplemental Figure 8C ), muscle (Supplemental Figure 8F) , and adipose tissue (Supplemental Figure 8I) . To test the time spent to be absorbed and activate GPR receptors, we carried out a time-course experiment. FS was chosen to this test due its high capacity on GPR120/40 activation on liver (D), muscle (E and F), and adipose tissue (G). In both experiments, samples contenting 1.0-mg total protein extracts from tissues were incubated with ␤-arrestin (A-F) antibody. The immunocomplexes were recovered with protein A Sepharose and, under denaturing conditions, separated by SDS-PAGE. Nitrocellulose transfers were blotted (IB) with GPR120 (A-E and G) or GPR40 (F) antibodies. Loading was evaluated by reprobing the membranes with anti-␤-arrestin (A-G). In all experiments, n ϭ 5; *, P Ͻ .05 vs HF, FS, or OL or P Ͼ .05 to mean values followed by the same letter in the bars by Tukey's test.
Immunoneutralization and knockdown of GPR120 inhibits its activation by 3 fatty acid Lean mice were fasted for 8 hours and then treated with a single dose of anti-GPR120 antibody (1.25 g/100 L by ip) or 3 different sequences of lentivirus (10 7 /100 L via caudal vein). After an additional 3 hours, mice received 500 L of FS by gavage. As shown in Supplemental Figure  9 , the immunoneutralization of GPR120 completely inhibited the FS-induced activation of GPR120/␤-arrestin association and the downstream proinflammatory pathway in liver (Supplemental Figure 9 , A, D, and G), muscle (Supplemental Figure 9 , B, E, and H) and adipose tissue (Supplemental Figure 9 , C, F, and I), respectively. In animals treated with lentivirus sequences, only sequences 1 and 2 had efficient effect in to block GPR120/␤-arrestin association. However, this approach was effective only in liver (Supplemental Figure 9J ) and muscle (Supplemental Figure 9K ) but not in adipose (Supplemental Figure 9L) .
Discussion
In 1979, the classic Eskimos study carried out by Dyerberg and Bang (18) was the first to show the beneficial effects of 3 fatty acids altering cyclooxygenase function. Thereafter, 3 fatty acids have been explored exhaustively, and additional antiinflammatory mechanisms have been determined. However, only recently were GPCRs identified as membrane receptors that transduce some of the activities of 3 fatty acids (6 -8) .
Metabolic inflammation present in obesity is one of the most important factors leading to insulin resistance and to a number of comorbidities that threaten the quality of life and lifespan of affected subjects (2) . Recent studies have shown that at least some of the beneficial effects of 3 and 9 fatty acids on human health are due to their antiinflammatory properties. However, few studies have evaluated GPR120 as a mediator of at least part of these effects (7, 8) . Here, we used an animal model of diet-induced obesity and type 2 diabetes to further explore GPR120 as a mediator of the metabolic effects of 3 and 9 fatty acids.
Because of the undisputed evidence of dietary intervention on human health (19), we focused on the effects of dietary 3 and 9 fatty acids. Both FS and OL substitutions resulted in a significant decrease of caloric intake occurring in the first 2 weeks after diet change and remaining steady thereafter. Based on a previous study (8) , we believe that the anorexigenic effect of the substituted diets is mostly due to reduced hypothalamic inflammation. Because reduced caloric intake resulted in lower body mass, we performed a caloric pair-feeding experiment to exclude the possibility that the whole-body metabolic improvement was due to reduced adiposity. Even with similar body mass, mice on HF retained the insulin resistance phenotype, reinforcing the beneficial role of dietary 3 and 9 fatty acids. It is noteworthy that the reduction in body adiposity is accompanied by a reduction in inflammation in adipose tissue. This is in line with a previous study (20) , showing that a reduced number and size of adipocytes in distinct fat deposits in overweight humans directly correlated with the presence of 3 and 9 fatty acids in the tissue.
Next, we evaluated the effect of fatty acid substitution on whole-body insulin action and glucose homeostasis. Similarly to the effect on food intake, the substituted diets led to a complete restoration of insulin action and glucose homeostasis to levels similar to those in lean controls, independent of the fatty acid type. Because the effect of fatty acid substitution on body mass was independent of the quality of the unsaturated fatty acids, we believe the effect on insulin action and glucose homeostasis was due to the presence of increased amounts of unsaturated fatty acids in the diets and not secondary to body mass reduction. Mejía-Barradas et al (21) found improvements on the anthropometric parameters of adolescents submitted to increased 3 consumption and attributed the outcomes to the down regulation of lipogenic factors, such as sterolregulated element binding protein and peroxisome proliferator activated receptor-␥. However, the control of glucose homeostasis may be due to additional mechanisms. Recently, oleic fatty acids were shown to mediate insulin secretion by activating GPR40 in the pancreas (22) and to induce cholecystokinin release in the small intestine (23) , further improving the central control of food intake. Moreover, free oleic fatty acid, or oleoylglycerol, can activate a GPR119-releasing glucagon-like peptide-1/2 in the small intestine, thereby improving insulin actions (24) . GPR120 is another fatty acid receptor found in the intestine; the activation of GPR120 has been shown to stimulate GLP-1 release. Thus, although ␣-linolenic acid and docosahexaenoic acid were found to be full GPR120 agonists in vitro, oleic acid only secondarily activated the receptor, indicating that GPR120 is primarily activated by 3 fatty acids (23) .
The improvement in glucose homeostasis obtained in the present study is certainly an outcome of reduced inflammation and improved insulin signal transduction in the main metabolic tissues (24 -26) . However, it is noteworthy that 3 and 9 fatty acid substitutions had a particularly important effect on the liver. In the liver, the substitutions resulted in improved steatosis, increased 3 and 9 fatty acid deposits, reduced expression of markers of inflammation and, finally, reduced expression or activity press.endocrine.org/journal/endoof proteins involved in gluconeogenesis. Because of the important role of hepatic glucose production in wholebody glucose homeostasis (15), we believe that hepatic glucose production accounts for much of the metabolic effect produced by the substitutions. In addition, Imamura et al (27) hypothesized that a subunit of G protein (G␣q 11 ) acts directly activating phosphatidylinositol 3-kinase in 3T3 adipose cells. Oh et al (7) tested this hypothesis and showed that G␣q 11 is activated by 3 fatty acids through GPR120 receptor with or without inflammation. These results suggest that cells could have adopted another strategy to activate insulin pathway mediated by fatty acids. However, this issue requires further investigation. The role of unsaturated fatty acids in antiinflammatory activity has been highlighted since the first reports describing the beneficial effects of these nutrients for human health (7, 8, 18) . Here, we demonstrate a consistent reduction of inflammatory markers in different tissues of mice fed on substituted diets. We expect that some, if not all, of the antiinflammatory mechanisms induced by unsaturated fats in combination produce the final outcome herein reported. However, the main objective of this study was to determine the impact of GPR120 signaling as a mediator of these actions.
As recently described (7), ligand binding induces conformational changes in GPR120, resulting in the recruitment of ␤-arrestin and the subsequent impairment of inflammatory signaling through TAB1/2. Important inflammatory signaling pathways, such as Toll Like Receptor 4 and TNF␣, transduce their signals through TAB1/2 (7, 28) . Thus, under GPR120 activation, intracellular inflammatory signal transduction is inhibited (7, 8) . In fact, mice fed on substituted diets presented an activation of GPR120 signaling in the liver, muscle, and adipose tissue. This was accompanied by the reduced expression of inflammatory markers and increased expression of IL-10, an antiinflammatory cytokine (8, 15) . In accordance with the previously mentioned results, a new class of synthetic GPR120 ligands was recently described (29) and mimicked all effects of 3 fatty acids, which allows it be used as a new strategy against type 2 diabetes mellitus. Some recent studies have shown that in different tissues involved in the control of metabolic activity, IL-10 has beneficial effects (31) . Thus, we propose that in addition to the reduction in classic inflammatory activity, the increase in IL-10, an important antiinflammatory mediator, plays a role in the metabolic effects of the 3 and 9 fatty acids.
In the final part of the study, we used an immunoneutralizing antibody to dampen GPR120 activity. A similar approach has been tested previously with reproducible results (15, 32) . Under specific antibody treatment, 3 and 9 fatty acids could no longer activate signal transduction through this receptor, providing further support for the Figure 7 . GPR120 antiinflammatory schematic mechanism. Nevertheless, some authors (18, 19 ) appoint 3 or 9 as GPCRs activators in the gut, beginning their actions even before absorption, releasing GLP-1. When they reach the circulation, 3 or 9 could further increase insulin release, mediated by the GPCRs activation directly in the pancreas.
important role of GPR120 as a mediator of some of the effects of dietary saturated fats.
As a whole, this study provides evidence for the beneficial metabolic effects of 3 and 9 fatty acids present in the diet. It extends the findings of previous studies showing that the whole-body effects are a result of the action of the nutrients in different metabolically relevant tissues (Figure 7) . Our results reinforce the role of correct nutritional approaches for the control of complex metabolic disorders.
